Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 2025 of 3284 entries
View as:

A Study Comparing Cardiovascular Effects of Ticagrelor and Clopidogrel in Patients With Peripheral Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT01732822 Org: User:
Start: 12/04/12 End: 09/26/16 Due: 09/26/17

A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection

Phase: N/A Priority: Normal
NCT ID: NCT02491684 Org: User:
Start: 07/21/15 End: 11/24/16 Due: 11/24/17

Canadian, Multi-Centre Study of Symptom Burden and Clinical Management in Subjects With GERD

Phase: N/A Priority: Normal
NCT ID: NCT00634023 Org: User:
Start: 01/31/08 End: 05/31/08 Due: 05/31/09

A Study to Assess the Pharmacokinetics of AZD6793 When Administered Alone and in Combination With Itraconazole in Healthy Participants.

Phase: N/A Priority: Normal
NCT ID: NCT06494644 Org: User:
Start: 07/23/24 End: 10/05/24 Due: 10/05/25

Study of an Extended Release (ER) Tablet, Single and Repeated Dosing

Phase: N/A Priority: Normal
NCT ID: NCT00689039 Org: User:
Start: 04/30/07 End: 07/31/08 Due: 07/31/09

Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults

Phase: N/A Priority: Normal
NCT ID: NCT04973449 Org: User:
Start: 06/27/21 End: 08/02/22 Due: 08/02/23

Arimidex: Compliance and Arthralgias in Clinical Therapy (COMPACT)

Phase: N/A Priority: Normal
NCT ID: NCT00857012 Org: User:
Start: 04/30/09 End: 02/29/12 Due: 02/28/13

Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)

Phase: N/A Priority: Normal
NCT ID: NCT05454787 Org: User:
Start: 06/02/22 End: 11/30/25 Due: 11/30/26

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT06921785 Org: User:
Start: 05/06/25 End: 03/15/30 Due: 03/15/31

CRT( Chemo-Radiation Therapy) Patterns and Short-term Outcomes on Unresectable NSCLC and SCLC in Routine Practices in Russia

Phase: N/A Priority: Normal
NCT ID: NCT05887011 Org: User:
Start: 03/31/23 End: 06/30/26 Due: 06/30/27

Efficacy of SEROQUEL in Selective Serotonin Reuptake Inhibitors (SSRI)-Resistant Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT00733668 Org: User:
Start: 03/31/06 End: 11/30/07 Due: 11/30/08

AZD6765 Severe Major Depressive Disorder (MDD) IV

Phase: N/A Priority: Normal
NCT ID: NCT00781742 Org: User:
Start: 10/31/08 End: 03/31/10 Due: 03/31/11

Assessing a Stool Symptom Screener in Patients With Chronic Opioid-Induced Constipation

Phase: N/A Priority: Normal
NCT ID: NCT01645371 Org: User:
Start: 08/31/12 End: 02/28/13 Due: 02/28/14

A Study of Verinurad and Allopurinol in Patients With Chronic Kidney Disease and Hyperuricaemia

Phase: N/A Priority: Normal
NCT ID: NCT03990363 Org: User:
Start: 07/23/19 End: 11/22/21 Due: 11/22/22

A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM)

Phase: N/A Priority: Normal
NCT ID: NCT00746382 Org: User:
Start: 11/30/08 End: 09/30/09 Due: 09/30/10

A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)

Phase: N/A Priority: Normal
NCT ID: NCT05526755 Org: User:
Start: 03/06/23 End: 11/29/29 Due: 11/29/30

Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, and Formoterol Delivered by BGF MDI HFO Compared With BGF MDI HFA

Phase: N/A Priority: Normal
NCT ID: NCT05477108 Org: User:
Start: 07/29/22 End: 04/11/23 Due: 04/11/24

eVusheld Assessment reaL wORld Effectiveness in DoD Health System

Phase: N/A Priority: Normal
NCT ID: NCT05569408 Org: User:
Start: 08/10/23 End: 12/22/23 Due: 12/22/24

A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice

Phase: N/A Priority: Normal
NCT ID: NCT05637112 Org: User:
Start: 02/27/23 End: 03/19/31 Due: 03/19/32

A Study to Assess the Long- Term Safety of TC-5214 as an Adjunct Therapy in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT01152554 Org: User:
Start: 06/30/10 End: 02/29/12 Due: 02/28/13

Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNs

Phase: N/A Priority: Normal
NCT ID: NCT06175637 Org: User:
Start: 12/20/23 End: 11/30/27 Due: 11/30/28

Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT01563978 Org: User:
Start: 04/30/12 End: 01/31/13 Due: 01/31/14

Real World Assessment of Clinical Outcome Changes -Including Month of Ramadan-for Dapagliflozin in Management of Type II Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT02805361 Org: User:
Start: 08/21/16 End: 07/13/18 Due: 07/13/19

Study to Evaluate Efficacy and Safety of Tezepelumab in Reducing Oral Corticosteroid Use in Adult Patients With Severe Asthma

Phase: N/A Priority: Normal
NCT ID: NCT05274815 Org: User:
Start: 05/17/22 End: 09/09/24 Due: 09/09/25

Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

Phase: N/A Priority: Normal
NCT ID: NCT05624450 Org: User:
Start: 12/13/22 End: 06/19/26 Due: 06/19/27